CSIMarket
 
Catalyst Biosciences Inc   (CBIO)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 



EARNINGS REPORT by CSIMarket

Recorded Loss but Revenues Unchanged

Catalyst Biosciences Inc announced fiscal time frame ending Dec 31 2020 operating shortfall of $-18.841 millions

closeup_By_Jean-Etienne_Minh-Duy_Poirrier_from_Bruxelles_Belgium_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_CommonsFor the fiscal time frame ending Dec 31 2020 Catalyst Biosciences Inc lost money of $-0.85 per share compare to $-1.13 a year ago and increased losses from $-0.73 per share from the previous quarter.

Sales remained unchanged to $2 millions from $0 millions in the same quarter a year ago and sequentially Sales doubled by 127.44 % from $1 millions.



For the fiscal time frame ending Dec 31 2020 Catalyst Biosciences Inc realized net loss of $-18.907 million, bigger than $-13.609 million a year ago.

Catalyst Biosciences Inc reported net loss of $-56 millions and Sales of $21 millions for the fiscal year 2020.

Biotechnology & Drugs Company has decreased it's loss per share to $-2.93 from $-4.60 in the previous fiscal year, while by 0 % from $0 millions a year ago.

Catalyst Biosciences Inc is expected to report next financial results on March 03, 2022.


    Recently Reported Results
Red_pill_wikipedia_By_FML_(Own_work)_[CC-BY-SA-2.5_(http_creativecommons.org_licenses_by-sa_2.5)]_via_Wikimedia_Commons Cytodyn inc

Logged a Loss but Revenues Unchanged

For the fiscal time frame ending Dec 31 2020 Catalyst Biosciences Inc lost money of $-0.85 per share compare to $-1.13 a year ago and increased losses from $-0.73 per share from the previous quarter.

Sales remained unchanged to $2 millions from $0 millions in the same quarter a year ago and sequentially Sales doubled by 127.44 % from $1 millions.

Cytodyn Inc reported operating loss of $-30.785 millions, in the fiscal period ending Feb 28 2021, a deterioration from the operating shortfall of $-22.074684 millions, realized in third quarter of 2020

CYDY stock quotes, charts, profile

Growth Rates, Profitability, PE

pumping-gas Producer Price Index

Wholesale prices grow less then a month ago

U.S. Producer price index continued to rise in February, but on the lower pace.

drilling_engineering_lathe_manufacturing_machine_metal_industrial_machining-771478 Enertopia Corp

Enertopia Corp announced most recent fiscal period operating loss of $-0.327792 millions

Enertopia Corp announced operating loss of $-0.327792 millions, in the most recent fiscal period, a change from the operating shortfall of $-0.055649 millions, recorded in the same quarter a year ago.


ENRT stock quotes, charts, profile

Growth Rates, Profitability, PE

Messe_2012_by-RaBoe_127_Ra_Boe_Wikipedia__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Nanovation Microtech Inc

Nanovation Microtech Inc announced second quarter of 2021 operating shortfall of $-0.00423 millions

In the second quarter of 2021 Nanovation Microtech Inc loss increased of $-0.12 per share compared to $0.00 a year ago and improved from $-0.38 per share from the previous quarter.

Nanovation Microtech Inc reported operating shortfall of $-0.00423 millions, in the second quarter of 2021, an improvement from the operating shortfall of $-0.055649 millions, realized in second quarter of 2020

NANN stock quotes, charts, profile

Growth Rates, Profitability, PE

cable_wire_bare_copper_wire_factory-1069871 Cannabics Pharmaceuticals Inc

Sales and Earnings Unchanged

In the fiscal period ending Feb 28 2021 Cannabics Pharmaceuticals Inc reached break-even of $0.00 per share compared to $-0.00 a year ago and from $-0.01 per share from the previous quarter.

Sales remained unchanged to $0.00 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.

CNBK stock quotes, charts, profile

Growth Rates, Profitability, PE

house-1525913_960_720 Housing Starts

February housing starts fell by -10.3 %

The construction of new homes, as well as the issuance of new building permits declined in February, signaling slowdown in economic growth and decrease in business profitability.

Kitchen_stuff_By_Smoth_007_from_Christchurch_New_Zealand__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons Durable Goods Orders

New Orders 4.59 % in January

Durable Goods orders continued to grow, as bookings outgrow production.

Factory Orders (Picture Autor: Wolfgang Meinhart) licence GNU Factory Orders

New Orders up 3.21 % in January

Factory orders continued to grow, as bookings outgrow production.

Inside_Store_pd Citi Trends inc

Citi Trends Inc announced fourth quarter of 2020 operating income of $23.699 millions

Company displayed pleasant results in the fourth quarter of 2020. Sales were at $251.92 millions higher by 19.39% year on year and improved by 26.53 % quarter on quarter, while earnings per share more than doubled by 114.78 % to $1.80, sequentially eps more than doubled by 169.28 %.


In the fiscal year 2020, Citi Trends Inc reported Sales of $783.29 millions and net income of $23.98 millions.

Eps soared by 64.54 % to $2.32 per share from $1.41 in the previous fiscal year, while Sales increased by 0.18 % from $781.93 millions a year ago.

CTRN stock quotes, charts, profile

Growth Rates, Profitability, PE

pexels-photo-164571 Teardroppers Inc

Break-even, Sales very Strong

Teardroppers Inc announced earnings per share of $-0.00 and Sales of $0.02 millions in the financial time frame ending Dec 31 2020, Company's reached break-even per share, versus $-0.00 eps, earned in the same quarter a year ago, although Teardroppers Inc saw its Sales rise by 50.85% in the same period.

In contrast to the third quarter Sales increased by 3.89 % from $0.02 millions and from $0.00 per share.
In the fiscal year 2020, Citi Trends Inc reported Sales of $783.29 millions and net income of $23.98 millions.

Eps soared by 64.54 % to $2.32 per share from $1.41 in the previous fiscal year, while Sales increased by 0.18 % from $781.93 millions a year ago.

TRDP stock quotes, charts, profile

Growth Rates, Profitability, PE

balloon-hot-air-balloon-hot-air-balloon-ride-ballooning-163312 Genethera Inc

Sales and Earnings Unchanged

In the fourth quarter of 2020 Genethera Inc reached break-even of $-0.00 per share compared to $-0.01 a year ago and from $-0.01 per share from the previous quarter.

Genethera Inc reported operating deficit of $-0.132123 millions, in the fourth quarter of 2020, an improvement from the operating loss of $-0.239101 millions, realized in fourth quarter of 2019
Genethera Inc reported net loss of $-0.77 millions and Sales of $0.00 millions for the fiscal year 2020.

Net loss per share has widen to $-0.04 from $-0.01 in previous fiscal year, while by 0 % from $0.00 millions a year ago.

GTHR stock quotes, charts, profile

Growth Rates, Profitability, PE

tax-468440__340 High Sierra Technologies Inc

High Sierra Technologies Inc announced fourth quarter of 2020 earnings season operating shortfall of $-0.187955 millions

In the fourth quarter of 2020 earnings season High Sierra Technologies Inc increased losses of $-0.01 per share compared to $-0.00 a year ago and from $0.00 per share from the previous quarter.

High Sierra Technologies Inc reported operating deficit of $-0.187955 millions, in the fourth quarter of 2020 earnings season, a deterioration from the operating surplus of $0.012858 millions, realized in fourth quarter of 2019
Genethera Inc reported net loss of $-0.77 millions and Sales of $0.00 millions for the fiscal year 2020.

Net loss per share has widen to $-0.04 from $-0.01 in previous fiscal year, while by 0 % from $0.00 millions a year ago.

GLFO stock quotes, charts, profile

Growth Rates, Profitability, PE

Wells_Fargo_Center_at_Sunset_By_refractor_(Flickr)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Eaco Corp

EPS Drops, Sales Down Slightly

Eaco Corp realized a deterioration in earnings per share by -47.17% to $0.28 and Sales decrease by -1.9% to $55.75 millions in the financial period ending Feb 28 2021, year on year.

From the preceding quarter, eps soared from $0.17 per share and Sales increased by 4.4 % from $53.40 millions.

EACO stock quotes, charts, profile

Growth Rates, Profitability, PE

HK_CWB_World_Trade_Centre_office_lift_By_MARCO_LUOMEN_(Own-work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Cannapharmarx Inc

Company reports $-11.55 million loss, as impairment charges strip off $6.03 million from the fiscal time frame ending Dec 31 2020 results.

Company reports $-11.55 million loss, as impairment charges strip off $6.03 million from the fiscal time frame ending Dec 31 2020 results.

Cannapharmarx Inc reported operating shortfall of $-9.815889 millions, in the fiscal time frame ending Dec 31 2020, a deterioration from the operating shortfall of $-7.985159 millions, realized in fourth quarter of 2019
Cannapharmarx Inc reported net loss of $-19.89 millions and Sales of $0.00 millions for the fiscal year 2020.

Company has decreased loss per share to $-0.49 from $-0.66 in the previous fiscal year, while by 0 % from $0.00 millions a year ago.

CPMD stock quotes, charts, profile

Growth Rates, Profitability, PE



Other CBIO's Earnings Reports

Catalyst Biosciences Inc reported third quarter 2020 earnings

Catalyst Biosciences Inc reported second quarter 2020 earnings

Catalyst Biosciences Inc reported first quarter 2020 earnings

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SOGO's Profile

Stock Price

SOGO's Financials

Business Description

Fundamentals

Charts & Quotes

SOGO's News

Suppliers

SOGO's Competitors

Customers & Markets

Economic Indicators

SOGO's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright Š 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071